BDBM636782 US20230382863, Compound I-2
SMILES CC1=C(C(=C(N(C1=O)C)Nc2ccc(cc2F)I)C(=O)NC3CC3)Oc4cccc(c4Cl)NS(=O)(=O)NC
InChI Key InChIKey=RDFUWPLPCIAPFU-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 6 hits for monomerid = 636782
TargetMitogen-activated protein kinase kinase kinase 1/RAF proto-oncogene serine/threonine-protein kinase(Human)
Ikena Oncology
US Patent
Ikena Oncology
US Patent
Affinity DataKd: 0.144nMAssay Description:Table 11: The experiments were performed on Biacore S200 (Cytiva). Biotinylated, unphosphorylated MEK1 was diluted to 0.1 uM by SPR buffer C (20 mM T...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 1/RAF proto-oncogene serine/threonine-protein kinase(Human)
Ikena Oncology
US Patent
Ikena Oncology
US Patent
Affinity DataKd: 0.370nMAssay Description:Table 8: Exemplary MEK inhibitor compounds (0, 0.01, 0.1, or 1 μM) were added to a 384-AlphaPlate (PerkinElmer, 6008350) by a digital liquid dis...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 1/RAF proto-oncogene serine/threonine-protein kinase(Human)
Ikena Oncology
US Patent
Ikena Oncology
US Patent
Affinity DataKd: 0.370nMAssay Description:Table 8: Exemplary MEK inhibitor compounds (0, 0.01, 0.1, or 1 μM) were added to a 384-AlphaPlate (PerkinElmer, 6008350) by a digital liquid dis...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 1/RAF proto-oncogene serine/threonine-protein kinase(Human)
Ikena Oncology
US Patent
Ikena Oncology
US Patent
Affinity DataKd: 0.370nMAssay Description:Table 8: Exemplary MEK inhibitor compounds (0, 0.01, 0.1, or 1 μM) were added to a 384-AlphaPlate (PerkinElmer, 6008350) by a digital liquid dis...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 1/RAF proto-oncogene serine/threonine-protein kinase(Human)
Ikena Oncology
US Patent
Ikena Oncology
US Patent
Affinity DataKd: 1nMAssay Description:Table 8: Exemplary MEK inhibitor compounds (0, 0.01, 0.1, or 1 μM) were added to a 384-AlphaPlate (PerkinElmer, 6008350) by a digital liquid dis...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 1/Serine/threonine-protein kinase B-raf(Human)
Ikena Oncology
US Patent
Ikena Oncology
US Patent
Affinity DataIC50: 100nMAssay Description:Table 3: Compound effects on binding affinity of MEK to BRAF or CRAF were followed by surface plasmon resonance (SPR) with single-cycle kinetic analy...More data for this Ligand-Target Pair

3D Structure (crystal)